Nomura Holdings
SRPT icon

Nomura Holdings’s Sarepta Therapeutics SRPT Stock Holding History

Nomura Holdings’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-38,400
Closed -$826K – 2092
2025
Q4 		$826K Sell
38,400
-113,500
-75% -$2.39M ﹤0.01% 1393
2025
Q3 		$2.93M Buy
151,900
+53,700
+55% +$957K ﹤0.01% 991
2025
Q2 		$1.68M Buy
98,200
+7,100
+8% +$303K ﹤0.01% 878
2025
Q1 		$5.81M Buy
91,100
+52,400
+135% +$5.52M 0.01% 663
2024
Q4 		$4.71M Buy
38,700
+36,200
+1,448% +$4.44M 0.01% 788
2024
Q3 		$312K Sell
2,500
-27,700
-92% -$3.83M ﹤0.01% 1334
2024
Q2 		$4.77M Buy
+30,200
New +$3.88M 0.01% 671
2020
Q1 		– Sell
-20,000
Closed -$2.58M – 1201
2019
Q4 		$2.58M Buy
+20,000
New +$2.02M 0.01% 599
2018
Q1 		– Sell
-1,100
Closed -$61K – 1656
2017
Q4 		$61K Sell
1,100
-411,500
-100% -$21.8M ﹤0.01% 1488
2017
Q3 		$18.7M Buy
+412,600
New +$16.5M 0.04% 253
2017
Q1 		– Sell
-273,000
Closed -$7.58M – 1595
2016
Q4 		$7.58M Buy
+273,000
New +$11M 0.02% 440

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nomura Holdings's SRPT Position: Q4 2025 in Review

Nomura Holdings sold out of Sarepta Therapeutics (SRPT) in Q4 2025, closing a stake of 27,515 shares — an estimated $580K sold.

Nomura Holdings first reported a position in SRPT in Q3 2014 and held it in 22 quarters. The position peaked at $24.9M in Q1 2019. 345 funds tracked by Wall St. Rank hold SRPT as of Q4 2025.

  • Nomura Holdings reported no remaining Sarepta Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Nomura Holdings sold 27,515 Sarepta Therapeutics shares in Q4 2025, an estimated $580K.
  • Nomura Holdings first reported a position in Sarepta Therapeutics in Q3 2014 and held it in 22 quarters.
  • Nomura Holdings's Sarepta Therapeutics position peaked at $24.9M in Q1 2019.
  • 345 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q4 2025.

Based on Nomura Holdings's 13F filing for Q4 2025, filed 17 Feb 2026.